Quick Answer
Sionna Therapeutics, Inc. reported Total Assets of $325.95 million for fiscal year 2025.
Sionna Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $325.95M | +75.5% |
| 2024 | $185.75M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $339.27M | — | -3.6% |
| June 30, 2025 | $352.05M | — | -4.8% |
| March 31, 2025 | $369.67M | — | +99.0% |
| December 31, 2024 | $185.75M | — | — |
- Sionna Therapeutics, Inc. showed an increase of +75.5% in Total Assets compared to the prior fiscal year.
- Over the 2024–2025 period, Sionna Therapeutics, Inc.’s total assets has grown by 75.5% (from $185.75 million to $325.95 million).
- The most recent figure is from Sionna Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: